The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zanaflex 4 mg Tablets

PCO Manufacturing Ltd.PPA0465/474/002

Main Information

Trade NameZanaflex 4 mg Tablets
Active SubstancesTizanidine
Dosage FormTablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/474/002

Group Information

ATC CodeM03BX Other centrally acting agents
M03BX02 tizanidine


License statusAuthorised
Licence Issued21/05/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back